Two interrelated cellular processes are invoked simultaneously upon induction of dierentiation, the regulated progression of cells through successive stages of cell dierentiation and growth inhibition which ultimately leads to growth arrest. In tissues with rapid cell turnover terminally dierentiated cells undergo programmed cell death. Terminal dierentiation, thus, represents one form of negative growth control. It was surmised that the molecular engine which drives the dierentiation process forward requires induction of positive regulators of terminal cell dierentiation, to be found among dierentiation primary response genes, as well as suppression of negative regulators, which correspond to genes which control cellular growth. This line of thought has prompted the isolation of myeloid dierentiation primary response (MyD) genes activated in the absence of de novo protein synthesis, upon IL-6 induced terminal dierentiation of murine M1 myeloblastic leukemia cells, where the cells growth arrest and ultimately undergo programmed cell death. As delineated in this review many of the genes identi®ed as MyD genes, including both known genes [IRF-1, (AP-1)Fos/Jun.EGR-1] and novel ones (MyD88, MyD116, MyD118), turned out to play a role in negative growth control, including growth suppression and apoptosis, in many cell types, of both hematopoietic and non hematopoietic origins.
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Terminal dierentiation, negative growth control, and MyD genes
Animal cells respond to dierentiation signals which turn on or o the appropriate genes, resulting in the conversion of proliferating, undierentiated cells into nonproliferating, highly specialized dierentiated cells. Two interrelated cellular processes are invoked simultaneously upon induction of dierentiation, the regulated progression of cells through successive stages of cell dierentiation and growth inhibition which ultimately leads to growth arrest. In tissues with rapid cell turnover terminally dierentiated cells undergo programmed cell death. Thus, terminal dierentiation can be viewed as one form of negative growth control. A profound example of this process, which continues throughout life, is the complex process of blood cell formation, whereby a hierarchy of hematopoietic progenitor cells in the bone marrow proliferate and terminally dierentiate along multiple, distinct cell lineages, including proliferation and terminal differentiation of cells along the myeloid lineage.
The ability to readily obtain normal bone marrow cells, and the availability of several dierentiation inducible hematopoietic cell lines, some being leukemic, make hematopoiesis an excellent model system to dissect the molecular genetics of normal cell development, including proliferation, dierentiation, growth arrest and apoptosis, and to study how genetic lesions which aect these processes contribute to oncogenicity and its progression.
Towards this end, we have surmised that the molecular engine which drives the dierentiation process forward requires induction of positive regulators of terminal cell dierentiation, to be found among dierentiation primary response genes, as well as suppression of negative regulators, which correspond to genes which control cellular growth ( Figure 1a ).
This line of thought has prompted the isolation of myeloid dierentiation primary response (MyD) genes activated in the absence of de novo protein synthesis, in the autonomously proliferating murine M1 myeloid leukemia cell line following induction for terminal dierentiation along the macrophage lineage (Lord et al., 1990a) . As shown in Figure 1b , upon stimulation of M1 cells by lung conditioned medium (LUCM), a potent physiological source for hematopoietic differentiation inducers, including interleukin-6 (IL-6) and Leukemia Inhibitory Factor (LIF), or by puri®ed recombinant IL-6 or LIF, M1 cells undergo terminal dierentiation which is associated with growth arrest and ultimately culminates in programmed cell death.
It is not surprising, therefore, as delineated in this review, that many of the genes identi®ed as MyD genes in our laboratory, including both known genes [IRF-1, (AP-1)Fos/Jun.EGR-1] (Abdollahi et al., 1991b; Lord et al., 1990d; Nguyen et al., 1993) and novel ones (MyD88, MyD116, MyD118) (Abdollahi et al., 1991a; Lord et al., 1990b,c) , turned out to play a role in negative growth control, including growth suppression and/or apoptosis, of many cell types.
Interferon regulatory factor 1 (IRF-1) in negative growth control MyD32, highly expressed in normal myeloblast enriched bone-marrow cells, was found to encode for interferon regulatory factor-1 (IRF-1), (Abdollahi et al., 1991b) , a transcriptional activator of the interferonb (IFNb) gene (Fugita et al., 1989; Harada et al., 1990; Miyamoto et al., 1988) . Using M1 cells, induced for terminal dierentiation by either IL6 or LIF, it was shown that IRF-1 expression is rapidly induced in the absence of de novo protein synthesis. IFNb mRNA expression was observed to follow at a later time, and to be largely dependent on protein synthesis. It was also shown that the growth inhibition associated with IL6 or LIF induced terminal dierentiation could be partially abrogated using IRF-1 antisense oligomers or IFNb antiserum (Abdollahi et al., 1991b) . Taken together, these ®ndings have inferred a regulatory cascade, where induction of terminal myeloid differentiation by IL6 or LIF triggers the immediate early activation of IRF-1, leading to the later induction of IFNb, which in turn plays an autocrine role in growth inhibition (Figure 2 ). M1 cells, like their normal short lived hematopoietic counterparts (Squier et al., 1995) , undergo apoptosis at the end of the terminal dierentiation program (Figure 2 ). Whether IRF-1 plays a role in apoptosis associated with terminal dierentiation remains to be seen.
IRF-1, is expressed in many cell types (Fugita et al., 1989; Harada et al., 1990; Miyamoto et al., 1988; Reis et al., 1992; Yu-Lee et al., 1990) , where it appears to play a role as a tumor suppresser gene, whose loss of function leads to malignant transformation. Consistent with this notion, Harada et al. (1993) have shown that balanced expression of IRF-1 and IRF-2, an antagonistic repressor of IRF-1 and IFNb transcription, is critical for normal cell growth. Overexpression of IRF-2 in NIH3T3 cells resulted in transformation and enhanced tumorigenicity of the cells in nude mice, whereas simultaneous overexpression of IRF-1 and IRF-2 reverted this transformed phenotype. Additional support for the tumor suppressor activity of IRF-1 has been provided by Willman et al. (1993) , who demonstrated that the gene for IRF-1 maps to human chromosome 5q31.1, a region that is frequently deleted in leukemia and preleukemic myelodysplasia.
Targeted disruption of IRF-1 revealed a critical role for IRF-1 in T cell development, resulting in a profound reduction of TCRab+CD4-CD8+T cells. On the other hand, IRF-2-de®cient mice exhibit bone marrow suppression of hematopoiesis and B lymphopoiesis. This may be due to disregulated expression of IRF-1 in the hematopoietic cells which lack IRF-2 expression (Matsuyama et al., 1993) .
Further con®rmation of the growth suppressive eect of IRF-1 comes from studies using antisense techniques to inhibit IRF-1 expression in KG-1 and primary hematopoietic cells, stimulated with IFNg (Sato et al., 1997) . In contrast to the suppressive eects of IFNg in control cells, it stimulated proliferation of KG-1, and normal hematopoietic cells, where expression of IRF-1 was blocked by antisense RNA. The stimulatory eect of IFNg in these cells was shown to be associated with activation of Stat1 and Stat3, which implicates IRF-1 in the suppression of Stat activity.
Interestingly, the promoter regions of both IRF-1 and p53 were found to contain a common cis-acting sequence element, termed IRF-1 p53 common sequence (IPCS). The transcriptional activity of IPCS was shown to be strictly correlated with the binding of an IPCSbinding factor (IPCS-BF), thereby revealing that the expression of these two growth suppressive genes is under common regulation (Lallemand et al., 1997) .
Expansion of the regulatory links between IRF-1 and growth suppressive genes comes from observations made with mouse embryonic ®broblasts (MEFs) which lack IRF-1. It was found that IRF7/7 MEFs are de®cient in their ability to undergo DNA-damageinduced cell-cycle arrest (Tanaka et al., 1996) . Transcriptional activation of the cyclin dependent kinase inhibitor (CDKI) p21 gene in these cells by irradiation, was found to be dependent both on p53 and IRF-1. This observation provides an explanation for the compromised DNA-damage-induced cell-cycle arrest of the IRF7/7 MEFs. It also indicates that these two growth suppressive genes converge to regulate cell cycle arrest Terminal dierentiation can be viewed as one form of negative growth control. When cells terminally dierentiate they undergo growth arrest, and, in tissues with rapid cell turn over, ultimately undergo cell death. This process requires induction of dierentiation primary response genes, and suppression of genes that regulate cellular growth. (b) Myeloid dierentiation primary response (MyD) genes, activated in M1 myeloblastic leukemia cells upon induction of terminal differentiation (by LUCM, IL-6, or LIF) which culminates in programmed cell death (apoptosis), have been isolated in our laboratory. As delineated in this review, some of the MyD genes isolated, including both known (IRF-1, (AP-1)Fos/Jun.Egr-1) and novel (MyD88, MyD116, MyD118), turned out to play a more general role than originally anticipated in negative growth control, including growth suppression and apoptosis, in many cell types Figure 2 Role of the MyD gene IRF-1 in an autocrine loop which participates in growth inhibition associated with the terminal dierentiation program by activation of a common target gene. Supporting this ®nding is the observation that induction of IRF-1 in NIH3T3 cells, expressing IRF-1 under the control of the tetracycline-inducible promoter, correlated with increased expression of p21 and inhibition of cell growth (Nguyen and Hiscott, 1997) .
Evidence has accumulated that IRF-1 also plays a role in apoptotic cell death. MEFs from mice de®cient in IRF-1 expression were found to be transformed by expression of an activated c-Ha-ras oncogene. This property was not observed in MEFs from wild-type or IRF-27/7 mice. The transformed phenotype of ras-expressing IRF-17/7 MEFs could be suppressed by ectopic expression of IRF-1 cDNA. Moreover, it was observed that expression of the cHa-ras oncogene, when combined with a block to cell proliferation or treated by anti cancer drugs or ionizing radiation, resulted in apoptosis of the wildtype, but not the IRF-17/7, MEFs (Tanaka et al., 1994) . Taken together these observations indicate that IRF-1 is a critical determinant of oncogeneinduced apoptosis IRF-1 was found to be involved in other apoptotic pathways as well. DNA damage-induced apoptosis in mitogen-activated mature T lymphocytes, which is p53 independent, was observed to be dependent on IRF-1. Ectopic expression of IRF-1 in mature T cells or U937 cells resulted in activation of the endogenous gene for caspase 1 (ICE), and enhanced the sensitivity of these cells to radiation-induced apoptosis (Tamura et al., 1995 (Tamura et al., , 1996 . It has been proposed that IRF-1 interacts with Signal Transducers and Activator of Transcription (STATs) to induce the expression of caspase genes (Kumar et al., 1997; Hoey, 1997) . IRF-1 has been implicated also in apoptosis induced by IFNg in human colon adenocarcinoma HT-29 cells treated with various cytotoxic agents (Ossina et al., 1997) , in apoptosis of serum deprived and angiotensin II treated R3T3 cells (Horiuchi et al., 1997) , and apoptosis of PKR de®cient MEFs that were resistant to death induced by double-stranded RNA, TNFa, or LPS .
Whether IRF-1 plays a role in apoptosis associated with terminal dierentiation of hematopoietic cells remains to be seen.
AP-1 (Fos/Jun) transcription factors as positive and negative modulators of cell death
Pro-apoptotic function of Ap-1 in apoptosis associated with terminal dierentiation, cell development, and growth/survival factor withdrawal
The proto-oncogenes c-jun, junB, and junD were identi®ed as MyD genes which are stably induced during dierentiation of M1 myeloblastic leukemia cells, and normal myeloblasts (Lord et al., 1990a (Lord et al., ,d, 1991 (Lord et al., , 1993 , suggesting that they play key roles in the initiation, progression, and maintenance of the myelopoietic dierentiation program. Intriguingly, both c-fos and Jun (c-jun, junB, junD) mRNAs were observed to be stably induced during normal hematopoietic dierentiation, whereas only jun mRNAs was induced upon macrophage differentiation of the M1 myeloblastic leukemia cells (Lord et al., 1993; Liebermann and Homan-Liebermann, 1989) . High expression of Fos/Jun was also observed in terminally dierentiated cells of the megakaryocyte and mastocyte lineages (Distel and Spiegelman, 1990; Kreipe et al., 1986; Panterne et al., 1992) . These observations have prompted investigations of the role of c-Fos in terminal dierentiation of hematopoietic cells. Enforced expression of c-fos, and to a lesser extent junB, in M1 cells resulted both in an increased propensity of the cells to dierentiate in culture, and a reduction in the aggressiveness of the M1 leukemic phenotype in nude mice. Blocking Fos/Jun expression, using c-fos antisense oligomers, impaired dierentiation of normal, and M1, myeloblasts into mature macrophages and granulocytes, implicating fos/jun as positive modulators of hematopoietic dierentiation. Indeed, ample evidence has accumulated since to implicate AP-1(Fos/Jun) transcription factors in functional development of hematopoietic precursor cells along most, if not all, of the hematopoietic cell lineages, including the monocyte/macrophage, granulocyte, megakaryocyte, mastocyte, erythroid, and osteoclast lineages (reviewed in Liebermann et al., 1998) .
In the course of these studies, it was observed that M1 myeloid precursor cell lines expressing high levels of c-fos, comparable to what is observed in terminally dierentiated bone marrow, could not be established (Lord et al., 1993) .
These observations raised the possibility that high levels of c-fos expression in hematopoietic progenitor cells may be antagonistic to cell growth and/or cell survival. To study the eects of high level expression of c-fos, M1 cell lines which conditionally express high levels of c-fos have been established in our laboratory, using a retroviral vector encoding for a chimeric FosER protein, whose activity is dependent on the presence of b-oestradiol in the culture media. It was found that activation of Fos in M1 myeloid precursors resulted in G1 growth arrest, and loss of viability due to apoptotic cell death (unpublished). Since M1 cells are null for p53 expression (Selvakumaran et al., 1994b) , it is clear that Fosinduced apoptosis of M1 myeloblasts is independent of p53 expression. Furthermore, IL-6 was observed to protect M1 cells from Fos mediated apoptosis. Taken together, these observations indicate that AP-1 complexes, in addition to a role in hematopoietic dierentiation (Lord et al., 1993) , also function to control blood cell homeostasis by monitoring survival of hematopoietic progenitor cells.
Clearly, it remains to be determined under what physiological conditions Fos may be induced in immature blood cells to activate programmed cell death. Also, it remains to be determined what are the Fos partners which play a role in terminal dierentiation versus apoptosis, and which are the target genes that mediate these distinct AP-1 functions. Recently, AP-1 has been implicated in the regulation of proliferation and survival of erythroid cells as well, suggesting that dierent AP-1 factors play distinct roles in triggering apoptosis (JunB) versus protection from apoptosis (c-Jun) (Jacobs-Helber et al., 1998) .
Observations made by Smeye et al. (1992 Smeye et al. ( , 1993 were instrumental in suggesting that Fos/Jun may play a general role in apoptosis during early development and postnatally, upon terminal dierentiation of many cell types. Using fos-lacZ transgenic mice, containing a fos-lacZ fusion gene, it was demonstrated that continuous high expression of fos-lacZ is evident in skin, hair follicles, and bone cells undergoing terminal dierentiation which culminates in apoptotic cell death (Smeyne et al., 1992) . Using the same approach, it was also shown that high constitutive expression of fos was evident in sites of naturally occurring cell death (Smeyne et al., 1993) . Using Fos and c-jun de®cient mice, it was found that apoptosis can proceed normally during embryonic development of certain tissues and in some adult organs, such as the thymus and ovary, in the absence of Fos and/or Jun (Roer-Tarlov et al., 1996) . This may re¯ect functional redundancy of AP-1 complexes in promoting apoptosis in dierent cell types.
A pro-apoptotic function for Ap-1 was observed also in cell death induced by withdrawal of growth/ survival factors. For example, c-fos and c-jun were observed to be rapidly induced after growth factor deprivation in IL-6-and IL-2-dependent murine lymphoid cells (Colotta et al., 1992) . Blocking the expression of either c-fos or c-jun with antisense oligonucleotides increased lymphoid cell survival following IL-6 or IL-2 deprivation.
Another example for the pro-apoptotic function of AP-1 following withdrawal of growth/survival factor, is provided by studies conducted with primary rat sympathetic neurons, which are dependent on NGF for their survival (Estus et al., 1994) . Following NGF withdrawal the levels of c-Jun and c-Fos proteins were observed to be elevated in these neurons. Injecting into the cells neutralizing antibodies speci®c for either c-Jun or the Fos family of proteins (c-Fos, FosB, Fra-1 and Fra-2) protected the cells from apoptosis induced by NGF withdrawal, whereas antibodies against JunB and JunD, did not. Microinjection of an expression vector encoding a c-jun dominant negative mutant also protected sympathetic neurons from apoptosis induced by NGF deprivation, whereas overexpression of c-Jun was sucient to induce apoptosis (Ham et al., 1995) . Using dominantnegative or constitutively activated forms of various components of the JNK, p38 and ERK signaling pathways, has demonstrated that activation of JNK and p38, and concomitant inhibition of ERK, are critical for induction of apoptosis in PC12 cells deprived of NGF. These ®ndings suggest that inhibition of signaling via the growth/survival factor activated ERK pathway, and increased signaling via the stress-activated JNK/p38 pathway co-operate to promote neuronal cell death following deprivation of survival factors (Xia et al., 1995) .
A third example of AP-1 playing a positive role in apoptotic cell death associated with growth/survival factor withdrawal is provided by the studies of Preston et al. (1996) , who have analysed the role of c-Fos in programmed cell death of Syrian hamster embryo ®broblast cells, either highly susceptible (Sup Exposure of mammalian cells to UV light results in the UV response, which includes induction of many genes (Herrlich et al., 1994; Holbrook and Fornace, 1991) . Notably, there is an increase in the JNK/SAPK group of MAP kinases that results in increased AP-1 activity (Karin, 1995; Su and Karin, 1996 and therein) . In contrast to what has been discussed so far, a protective role for AP-1 against apoptosis induced by shortwavelength UV light (UVC) was observed when comparing the survival of mouse 3T3 ®broblasts that are null for c-fos expression to their wild type counterparts (Schreiber et al., 1995) , following exposure of the cells to UV light. Interestingly, the repair of UV-induced DNA lesions was not aected in the UVC susceptible fos7/7 3T3 ®broblasts, suggesting that c-Fos containing Ap-1 complexes are involved in a novel protective function against the damaging consequences of UVC.
Exposure of mammalian cells to ionizing radiation, like to UV light, results in the induction of immediate early genes, including the genes which encode for proteins of the Fos/Jun family (Weichselbaum et al., 1994) . It was shown that AP-1 also plays a protective role against the genotoxic eects of ionizing radiation. The survival of ®broblasts from patients with ataxia telangiectasia, expressing inducible dominant negative c-jun, was reduced upon induction of the dominant negative c-jun concomitant with X-irradiation (Hallahan et al., 1995) . These observations are consistent with the notion that Ap-1 factors composed of c-Jun participate in a growth response which plays a role in counteracting the DNA-damage induced cell cycle arrest, to enable cells to replace damaged DNA when the capacity of the DNA repair machinery has not been saturated, so that growth and cell cycle progression can be safely resumed (Devary et al., 1992) .
Increase in the expression of Fos/Jun proteins was also observed following exposure of cells (notably of hematopoietic origin) to various chemicals inducing DNA-damage, many of which are used as anti cancer agents. These include: etoposide (VP16, a topoisomerase II inhibitor) (Eliot et al., 1995; Gajate et al., 1996; Ritke et al., 1994; Rubin et al., 1991) , cytosine arabinoside (ara-C), and¯uorinated pyrimidines (pyrimidine nucleoside anti-metabolites) Gunji et al., 1991; Saleem et al., 1995) , and cisplatin (an alkylating agent) (Funato et al., 1992; Rubin et al., 1992) . Evidence that AP-1 transcription factors may play a protective role against the genotoxic eects of several of these anti cancer agents has been inferred by some of these studies.
In contrast to the ®ndings described above, AP-1 factors were observed to play a pro-apoptotic role in stress induced apoptosis which is mediated by ceramide or Fas ligand/Fas-receptor (CD95) signaling. Verheiij et al. (1996) , have shown that dominant-negative mutants of c-jun or JNKK/SEK1 block apoptosis induced by stress stimuli that generate ceramide (i.e. TNF-a, X-rays, UV light, hydrogen peroxide (H 2 O 2 ), heat shock) or by exogenously administrated ceramide, in U937 and BAE cells. As for Fas ligand/Fas-receptor (CD95) induced apoptosis, it was shown that both NFkB and AP-1 are crucial for expression of FasL induced by etoposide, teniposide, UV and g-irradiation. Cis acting elements in the FasL promoter were found to be responsive to p65 Rel and Fos/Jun, indicating that NF-kB and AP-1 directly regulate FasL expression (Kasibhatla et al., 1998; Faris et al., 1998) . On the¯ip side, it was observed that the Fas receptor itself activates the JNK pathway, which leads to AP-1 activation, via the receptor-associated protein Daxx, activating the JNK kinase kinase ASK1 (Chang et al., 1998) .
Interestingly, recently it was observed that c-Fos is degraded when WEHI7.2 mouse lymphoma cells are induced to undergo apoptosis with the calcium ATPase inhibitor, thapsigargin, or the glucocorticoid hormone, dexamethasone (He et al., 1998) . The degradation of cFos was found to precede caspase activation and apoptotic chromatin condensation and was inhibited by the proteasome inhibitors of the ubiquitin pathway. A c-Fos mutant that was not degraded by the proteasome pathway was found to inhibit apoptosis. Also overexpression of Bcl-2 inhibited apoptosis and blocked c-Fos degradation, suggesting that in this system, Bcl-2 promoted survival by preventing degradation of c-Fos.
In conclusion, AP-1 appears to be part of an intricate regulatory loop which modulates, both positively and negatively, stress induced apoptosis.
Egr-1 ±modulation of lineage speci®c dierentiation and role in DNA damage induced cell death
The zinc ®nger transcription factor Egr-1, which has been characterized as a MyD gene speci®cally induced upon terminal macrophage dierentiation, was shown to be essential for and to restrict dierentiation of hematopoietic progenitor cells along this lineage (Nguyen et al., 1993; Krishnaraju et al., 1995 Krishnaraju et al., , 1997 Krishnaraju et al., , 1998 . Recently, evidence has been obtained for a role of Egr-1 in apoptotsis.
Both Egr-1 and TNFa are induced upon irradiation induced apoptosis of prostate cancer cells that lack p53 (Ahmed et al., 1997) . Inhibition of Egr-1 was observed to abrogate both TNFa induction and apoptosis. Induction of TNFa by ionizing radiation was shown to be mediated via a GC-rich Egr-1-binding motif in the TNFa promoter, suggesting that, in the absence of p53, ionizing radiation-induced apoptosis is mediated by Egr-1 via TNFa trans-activation. Evidence has been obtained that Egr-1 also trans-activates the p53 promoter, where inhibition of p53 function abrogated Egr-1-dependent apoptosis. Additional evidence for a role for Egr-1 in apoptosis has been obtained in other cell systems as well, including B cell receptor-induced apoptosis in immature B cells (Muthukkuma et al., 1997; Dinkel et al., 1997) , apoptosis induced by Ca 2+ ionophor in melanoma cells (Muthukkuma et al., 1995) , and stress or growth factor induced apoptosis of neuronal cells (Goodenough et al., 1997; Mesner et al., 1995) . The mechanisms by which Egr-1 mediates apoptosis in dierent cell types, including cells of hematopoietic origin, remain to be elucidated.
MyD88 ± a signal transducer in IL-1 and Toll receptor signaling: a role in apoptosis and cell development MyD88 was originally characterized in our laboratory as a novel primary response gene in M1 cells induced to dierentiate by LUCM or IL-6. MyD88 mRNA was observed to rapidly accumulate following IL-6 stimulation (Lord et al., 1990c) . High levels of MyD88 expression were observed in bone-marrow cells, suggesting a role for this gene in blood cell development. Interestingly, MyD88 immediate early induction by IL-6 in M1 cells was observed to be mainly regulated at the level of mRNA stability (Lord et al., 1991) . In recent years it was observed that the MyD88 encoded protein (35kd) has a modular structure, consisting of an N-terminal death domain separated by a short linker from a C-terminal Toll domain (Feinstein et al., 1995; Hardiman et al., 1996; Hofmann and Tschopp, 1995; Hultmark, 1994; Mitcham et al., 1996; Yamagata et al., 1994) . The Nterminal death domain is related to a motif of about 90 amino acids that was originally de®ned as the region of similarity between the cytoplasmic tails of the FAS/ Apol/CD95 and TNF receptors required for their induction of cytotoxic signals (Itoh and Nagata, 1993; Tartaglia et al., 1993) . On the other hand, the MyD88 C-terminal Toll domain (*130 aa long) bears homology with the cytoplasmic signaling regions of the Drosophila melanogaster Toll receptor and the IL-1 receptor complex (Hashimoto et al., 1988; Medzhitov et al., 1997; Mitcham et al., 1996; Parnet et al., 1996) .
IL-1 is known to be an important mediator of in¯ammation, which participates in the defense response to environmental challenges by generating fever, activating lymphocytes, and mobilizing leukocytes to sites of injury and infection (Dinarello, 1996) . IL-1 exerts its eects by inducing the transcription of genes which encode for chemokines, cytokines, acutephase liver proteins, cell adhesion molecules, and enzymes involved in the production of pro-inflammatory substances (Dinarello, 1996; Barnes and Karin, 1997 ). An important mediator of the IL-1 signaling cascade is NF-kB (Baeuerle and Baltimore, 1996; Baldwin, 1996; Dinarello, 1996; Barnes and Karin, 1997) , which is rendered inactive in the cytoplasm of unstimulated cells by inhibitory proteins termed IkB. Upon exposure of cells to cytokines and a variety of stress stimuli, IkB proteins are phosphorylated on speci®c serine residues, and consequently are rapidly degraded, leading to nuclear translocation and activation of NF-kB Karin, 1998) . In recent years, it was found that stimulation of cells with IL-1 results in association of the IL-1 type I receptor (IL-1 Rl) with the receptor accessory protein (IL1RAcP) (Greenfeder et al., 1995; Huang et al., 1997; Korherr et al., 1997; Wesche et al., 1997b) . Consequently, the IL-1 receptor-associated serine/threonine kinase (IRAK) is recruited to the receptor complex, where it is phosphorylated (Cao et al., 1996a) . IRAK then dissociates from the receptor complex and interacts with TRAF6, that is required for IL-1-induced NF-kB activation (Cao et al., 1996b) . Two other TRAF (TNF-receptor associated factor) proteins, TRAF2 and TRAF5, have been implicated in NF-kB activation by the superfamily of TNF receptors (Aizawa et al., 1997; Duckett et al., 1997; Hsu et al., 1996a Hsu et al., , 1997 Ishida et al., 1996; Nakano et al., 1996; Rothe et al., 1995) , indicating that IL-1 and TNF signaling converge at the level of TRAF molecules. The kinase cascade which is distal to TRAF, and is responsible for NF-kB activation, also has been elucidated. It consists of a kinase complex that is composed of the TRAF interacting and NF-kB inducing kinase-(NIK), and two IkB kinases (IkKa and IkKb) that phosphorylate IkB on speci®c serine residues (Di Donato et al., 1997; Malinin et al., 1997; Mercurio et al., 1997; Regnier et al., 1997; Song et al., 1997; Woronicz et al., 1997; Zandi et al., 1997) .
The IL-1Rl and IL-1RAcP belong both to a conserved family of receptor like molecules, including IL-1 Rrp, IL-1Rrp2, T1/ST2, rsc786/TIL, human Toll in mammals (Yanagisawa et al., 1993; Lovenberg et al., 1996; Mitcham et al., 1996; Parnet et al., 1996; Medzhitov et al., 1997) , RPP5 in plants (Parker et al., 1997) , and 18 Wheeler and Toll in Drosophila melanogaster (Eldon et al., 1994; Hashimoto et al., 1988) . It was found that the Toll pathway in Drosophila governs an ancient innate immune response (Lemaitre et al., 1996) . In addition, this pathway controls dorsal-ventral polarization during early embryonic development (Wasserman, 1993; Belvin and Anderson, 1996; Norris and Manley, 1996) . Analogous to IL-1 signaling, activation of the cell surface receptor Toll by the extra cellular ligand Spaetzle was shown to lead to the phosphorylation and degradation of the IkB-like molecule Cactus, thereby releasing the NF-kB-like transcription factor Dorsal to translocate to the nucleus, where it regulates gene expression. Dorsal activation signaled by Toll requires two intermediate signal transducers, Tube and Pelle (Letsou et al., 1993; Norris and Manley, 1996; Shelton and Wasserman, 1993) . Pelle is a serine/ threonine kinase that is related by its sequence to IRAK, whereas Tube is an adapter molecule that links Pelle to the Toll receptor (Galindo et al., 1995; Grosshans et al., 1994) . Tube and Pelle were observed to interact via their N-terminal death domains, a motif which is also present in many other signal transducing molecules, including IRAK (Feinstein et al., 1995; Galindo et al., 1995; Cao et al., 1996a) .
Several reports in the last year have identi®ed MyD88 as an adapter that recruits IRAK to the IL-1 receptor complex Wesche et al., 1997a; Muzio et al., 1997) (Figure 3) . It was shown that following IL-1 stimulation MyD88 binds to both IRAK and the IL-1R/IL-1AcP receptor complex, thereby linking IRAK to the receptor. Ectopic expression of MyD88 or its N-terminus fragment, which harbors the death domain, was shown to activate NF-kB, whereas the C-terminus fragment, harboring the Toll domain, was shown to interact with the IL-1 receptor and to function as a dominant Figure 3 MyD88 is a signal transducer in signaling by the IL-1, IL-18, and Toll receptors. MyD88 has a modular structure, consisting of an N-terminal death domain (DD) separated by a short linker from a C-terminal Toll domain (TD). MyD88 has been identi®ed as an adapter that recruits the serine/threonine kinase IRAK to the IL-1, IL-18 or human Toll receptors (see text). MyD88 is upstream of a regulatory cascade, which via IRAK/TRAF interactions activates NF-kB and AP-1. MyD88 is, therefore, a mammalian homolog of Drosophila Tube, and a functional equivalent of TRADD, a signal transducer in TNF signaling. TRADD, on the one hand, interacts with RIP/TRAF2 to activate NF-kB and AP-1; on the other, it interacts with FADD to activate caspase 8 to induce apoptosis. MyD88 is capable of inducing apoptosis. Whether it functions like TRADD is not known negative which blocks NF-kB activation by IL-1, but not by TNF. Both the N-and C-terminal fragments of MyD88 were observed to interact with IRAK (Wesche et al., 1997a) . Formation of MyD88 homodimers, mediated via the death domain, was observed as well. Their role remains to be elucidated. Taken together, these ®ndings indicate that MyD88 is a mammalian homolog of Drosophila Tube, that couples a serine/ threonine protein kinase to the IL-1 receptor complex.
Identi®cation of MyD88 as an adapter molecule that recruits IRAK to the receptor complex further extends the conservation found in the signaling pathways for IL-1 and TNF, which are two major cytokines that activate NF-kB (Figure 3 ). The TNFR1 complex was shown to recruit the death domain-containing molecule TRADD (Hsu et al., 1995) , which mediates NF-kB activation and apoptosis. To activate NF-kB, TRADD interacts with serine/threonine kinase RIP and TRAF2, that are linked to the NIK/IkK cascade, and trigger the phosphorylation and degradation of IkB (Hsu et al., 1996a,b) . On the other hand, to induce cell death, TRADD interacts with FADD, which in turn triggers the apoptotic caspase cascade (Boldin et al., 1996; Grimm et al., 1996; Hsu et al., 1996a; Muzio et al., 1996) . Since in IL-1 signaling, MyD88 is responsible for recruiting IRAK, which interacts with TRAF6, it is the functional equivalent of TRADD in NF-kB activation by IL-1. Whether MyD88 plays a role in caspase activation remains to be seen.
Recently, MyD88 has been identi®ed also as an adapter for activation of NF-kB and AP-1, via the IRAK/TRAF6 cascade, in signaling by the human Toll-receptor (Medzhitov et al., 1998) . Molecular cloning of ®ve human Toll-like receptors, termed TLR1 to TLR5s, has been reported (Rock et al., 1998) . The TLRs are dierentially expressed in a variety of human tissues. Given the role of Toll signaling in Drosophila, it can be predicted that human Toll-like receptors play a role both in innate immunity and regulation of early morphogenetic patterning during embryonic development. Clearly, it will be of interest to identify the ligand(s) that interact with mammalian Toll-receptor, and to de®ne the role of MyD88, and MyD88 like molecules, in Toll signaling in mammals.
Gene targeting of MyD88 in mice has shown that mice lacking MyD88 have defects in T cell proliferation, as well as in the induction of acute phase liver proteins and cytokines in response to IL-1. Interestingly, these mice exhibit also defects in IL-18 signaling via the IL-1 related receptor-IL-IRrp. Both the increase in IFNg production and natural killer cell activity in response to IL-18 were compromised in MyD88-mice. Also, IL-18-induced activation of NFkB and JNK was impaired in MyD887/7 Th1-thymocyts. These observations indicate that MyD88 is a critical component in the IL-1 and IL-18 signaling cascades. The fact that MyD88 gene disruption was not lethal, and did not eect early embryo development in mice, is consistent with the notion that other MyD88 like molecules exist, and play critical roles in Toll signaling in mammals.
Recent work has shown that ectopic expression of MyD88 in human cervical carcinoma HeLa cell induces apoptosis (Jaunin et al., 1998) . It was also shown that the MyD88 protein is present both in the nucleus and in the cytoplasm of HeLa cells. These ®ndings, are similar to observations we have made in hematopoietic cells (unpublished) . In the cytoplasm MyD88 was found to be associated with ®brillar aggregates containing b-actin (Jaunin et al., 1998) . In the nucleus, MyD88 was observed to localize to novel ®brillar domains observed in cells prior to undergoing apoptosis. It has been suggested that these structures are involved in the formation of apoptotic bodies, alterations of the nuclear structure, and/or nucleocytoplasmic tracking during apoptosis.
Keeping in mind that MyD88 was originally discovered as an IL-6 myeloid dierentiation primary response gene, it is possible that it plays a role also in terminal dierentiation and homeostasis of blood cells.
MyD116 ± viral homologs and a protective role in apoptosis
MyD116 is the second novel MyD gene that was isolated in our laboratory (Lord et al., 1990b) . Like other MyD genes it is rapidly induced by IL-6 in M1, and expressed in bone-marrow cells. Unlike the stable prolonged expression of most MyD genes, MyD116 expression is cyclic. MyD116 is rapidly induced following M1 stimulation with IL-6, its expression declines at an intermediate stage of the M1 differentiation program, and is elevated again in the mature cells, prior to the point in time when they undergo apoptosis. Following its isolation, it became evident that MyD116 is the murine homolog of the growth arrest and DNA damage induced gene Gadd34, activated in hamster cells by growth arrest and DNA-damage stimuli, including alkylating agents and irradiation Zhan et al., 1994 ). An interesting feature of the MyD116/ gadd34 proteins is the almost perfect 38/39 aa long repeats, each containing a PEST motif, implicated in rapid protein turnover. Each PEST motif was observed to contain three potential casein kinase II phosphorylation sites, the function of which is still unclear. Interestingly, MyD116 contains 4.5 repeats, whereas Gadd34 harbors only 3.5 repeats. Cellular localization of the MyD116 protein has revealed that MyD116 is present both in the cytoplasm and in the nucleus of dierentiating M1 cells (unpublished). Using subtraction hybridization, a gene-termed PEG3, associated with transformation progression of virus-and oncogene-transformed rat embryo cells, has been cloned as a new member in the MyD116/Gadd34 family (Su et al., 1997) .
Short term transfection assays have shown that MyD116 suppresses colony formation of several human tumor cell lines including the RKO and H1299 colon carcinoma cell lines, and cervical carcinoma Hela cells. Whether the ability of MyD116 to suppress colony formation is due to growth inhibition, apoptosis or both of these phenomena remains to be determined. Using antisense oligos in the culture medium of M1 cells, has shown that blocking early expression of MyD116 promotes cell survival, whereas blocking its expression at late times promotes cell death (unpublished). The mechanisms by which MyD116 promotes survival or apoptosis in hematopoietic cells remain to be elucidated.
Interestingly the conserved carboxy terminal domain of MyD116, was found to share striking homology to the corresponding domain in the g(1)34.5 gene of herpes simplex virus (HSV) (McGeoch and Barnett, 1991) . The HSV g(1)34.5 gene was shown to be essential for establishment of acute infection in some human cell lines, including the SK-N-SH neuroblastoma cell line. g(1)34.5 deletion mutants, were observed to trigger a premature shuto of all protein synthesis, thereby rendering the cell non viable (Chou and Roizman, 1994) . The inability to prevent the cellular stress response that causes HSV infected cells to die, may explain the inability of g(1)34.5 deletion mutants to multiply and cause pathology in the central nervous system of mice. The g(1)34.5 domain necessary to preclude the total shuto of protein synthesis has been mapped to the carboxyl-terminal domain of the g(1)34.5 protein, which is highly homologous to the corresponding domains in MyD116 and GADD34 (Chou and Roizman, 1994) . These ®ndings are consistent with a protective function for g(1)34.5, and its MyD116 homology domain, in preventing cell death following viral infection. Additional experiments have shown that the carboxyl terminus of the murine MyD116 gene can substitute for the corresponding domain of the g(1)34.5 gene of HSV to preclude premature shuto of protein synthesis in infected human cells (He et al., 1996) . Recently the g(1)34.5 protein of HSV1 was found to complex with protein phosphatase-1a to dephosphorylate the a subunit of the eukaryotic translation initiation factor 2 to preclude the shuto of protein synthesis by doublestranded RNA-activated protein kinase. The MyD116 homology domain has been implicated in this interaction (He et al., 1997) . Also recently, it has been reported that IL-6 gene expression is up-regulated in HSV1 infected cells (Kanangat et al., 1996) . Since IL-6 induces MyD116, HSV may have adopted this cellular response to prevent cell death and facilitate acute infection. The existence of an African swine fever virus virulence-associated gene, termed NL-S, with similarity in its carboxy terminal domain to the MyD116 and the HSV g(1)34.5 protein, has been reported as well (Sussman et al., 1992; Vydelingum et al., 1993; Dixon et al., 1994; Zsak et al., 1996) . Whether other viruses harbor similar genes which promote cell survival upon infection remains to be seen.
Interestingly, both the g(1)34.5 gene of HSV and MyD116 were observed to interact, via their conserved C-terminal domains, with Proliferating Cell Nuclear Antigen (PCNA) (Brown et al., 1997) , an important player in DNA replication and DNA repair. The signi®cance of this interaction remains to be determined.
MyD118, Gadd45, and CR6 ± a family of growth suppressive and apoptotic proteins which interact with cell cycle proteins MyD118 was the third novel gene isolated in our laboratory (Abdollahi et al., 1991a) . Shortly after its isolation it became evident that MyD118 is related to the Gadd45 gene. The proteins encoded by these genes are 57% identical, indicating that MyD118 and Gadd45 represent two separate but closely related genes . A third member in the MyD118 gene family, CR6, has been cloned as well (Beadling et al., 1993; and unpublished) .
In the last few years, experimental evidence has accumulated that MyD118 and Gadd45 encode for proteins which function as important modulators of a variety of growth arrest and apoptotic pathways in hematopoietic and non-hematopoietic cells, including p53-independent and p53-dependent pathways (Vairapandi et al., 1996; Liebermann et al., 1995) . Among the stimuli which activate MyD118 and Gadd45, separately or in varying combinations are: differentiation inducing cytokines (i.e., IL-6, G-CSF, GM-CSF), growth inhibitory cytokines (i.e., TGF-b), genotoxic DNA damage inducing agents (i.e., MMS), or p53.
Several lines of evidence indicate that the proteins encoded by MyD118 and Gadd45, have similar, but not identical functions along dierent apoptotic and growth suppressive pathways. MyD118, but not Gadd45, is activated upon TGF-b1 induced apoptosis. In contrast, Gadd45, but not MyD118 is induced upon p53 mediated apoptosis. (Guillouf et al., 1998; Miyashita et al., 1994; Selvakumaran et al., 1994a; Zhan et al., 1994) . Still dierent, both MyD118 and Gadd45 are induced upon methyl methanesulfonate (MMS) induced apoptosis (Vairapandi et al., 1996) . Furthermore, whereas MyD118 is early expressed upon IL-6 induced dierentiation of M1 myeloblasts, Gadd45 is induced at late stages of the terminal dierentiation program (Vairapandi et al., 1996) . Furthermore, activation of an inducible MyD118 transgene in hematopoietic cells was observed to result in apoptotic M1 cell death (unpublished). Blocking the expression of MyD118 in M1 cells by an antisense vector was shown to impair TGFb induced cell death (Selvakumaran et al., 1994a) . Furthermore, blocking TGF-b induced apoptosis in M1 cells due to ectopic expression of bcl-2, was associated with down regulation of MyD118 transcripts; in contrast, deregulated expression of c-myc or c-myb in M1, abrogating TGF-b-induced growth arrest and accelerating apoptosis, was associated with marked elevations in the level of MyD118 transcripts (Selvakumaran et al., 1994a) . On the other hand, Gadd45 has been implicated in p53-mediated G1 cell cycle arrest following DNA damage (Kastan et al., 1992) . Short term transfection assays have revealed that MyD118 and Gadd45 synergize to suppress the growth and/or survival of several dierent human tumor cell lines .
MyD118 and Gadd45 encode for acidic proteins, which localize predominantly to the cell nucleus (Vairapandi et al., 1996) . Evidence has accumulated that MyD/Gadd proteins display a complex array of physical interactions, including homologous and heterologous interactions with each other, as well as with products of cell cycle regulatory genes. It was found that MyD118 and Gadd45 associate with PCNA Hall et al., 1995; Vairapandi et al., 1996) , which plays a central role in DNA repair and DNA replication (Mossi and Hubscher 1998; Prosperi, 1997; Jonsson and Hubscher, 1997) . MyD118 and Gadd45 were shown also to associate with the cyclin dependent kinase inhibitor p21 (Vairapandi et al., 1996) , known to interact with PCNA and to inhibit DNA replication Li et al., 1994; Flores-Rozas et al., 1994) . MyD118 and Gadd45 were also observed to enhance DNA excision repair activity in vitro Vairapandi et al., 1996) . The signi®cance of this remains to be determined. De®ning the protein domains which facilitate interactions of MyD118 and Gadd45 with each other, with PCNA and with p21, should provide tools to unravel the roles these proteins play in growth suppression and apoptosis.
